Protein-protein interfaces as druggable targets: A common motif of the pyridoxal-5’-phosphate-dependent enzymes to receive the coenzyme from its producers

Pyridoxal-5’-phosphate (PLP), a phosphorylated form of vitamin B6, acts as a coenzyme for numerous reactions, including those changed in cancer and/or associated with the disease prognosis. Since highly reactive PLP may modify cellular proteins, it is hypothesized to be directly transferred from its donors to acceptors. Our goal is to validate the hypothesis by finding common motif(s) in a multitude of the PLP-dependent enzymes for binding the limited number of the PLP donors, namely pyridoxal kinase (PdxK), pyridox(am)in-5’-phosphate oxidase (PNPO) and the PLP-binding protein (PLPBP). Experimentally confirmed interactions between the PLP donors and acceptors reveal that PdxK and PNPO interact with the PLP acceptors of folds I and II, while PLPBP – with those of folds III and V. Aligning the sequences and 3D structures of the identified interactors of PdxK and PNPO, we have found a common motif in the PLP-dependent enzymes of folds I and II. The motif extends from the enzyme surface to the neighborhood of the PLP binding site, represented by an exposed alfa-helix, a partially buried beta-strand and residual loops. Pathogenicity of mutations in human PLP-dependent enzymes within or in the vicinity of the motif, but outside of the active sites, supports functional significance of the motif that may provide an interface for the direct transfer of PLP from the sites of its synthesis to those of the coenzyme binding. The enzyme-specific amino acid residues of the common motif may be useful to develop selective inhibitors blocking PLP delivery to the PLP-dependent enzymes critical for proliferation of malignant cells.

[1]  Xiaoshun He,et al.  Vitamin B6 Metabolic Pathway is Involved in the Pathogenesis of Liver Diseases via Multi-Omics Analysis , 2022, Journal of hepatocellular carcinoma.

[2]  K. Ascenção,et al.  Emerging roles of cystathionine β-synthase in various forms of cancer , 2022, Redox biology.

[3]  R. Johnson,et al.  Vitamin B6 Metabolism Determines T Cell Anti-Tumor Responses , 2022, Frontiers in Immunology.

[4]  Nadezhda T. Doncheva,et al.  The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..

[5]  Kara Dolinski,et al.  The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions , 2020, Protein science : a publication of the Protein Society.

[6]  I. Nogués,et al.  Molecular characterization of pyridoxine 5′-phosphate oxidase and its pathogenic forms associated with neonatal epileptic encephalopathy , 2020, Scientific Reports.

[7]  V. Bunik,et al.  The multifaceted role of vitamin B6 in cancer: Drosophila as a model system to investigate DNA damage , 2020, Open Biology.

[8]  Review for "The multifaceted role of vitamin B 6 in cancer: Drosophila as a model system to investigate DNA damage" , 2020 .

[9]  Duc-Hau Le,et al.  Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses , 2020, bioRxiv.

[10]  S. Lowe,et al.  Vitamin B6 Addiction in Acute Myeloid Leukemia. , 2020, Cancer cell.

[11]  S. Sieber,et al.  Biochemical and Proteomic Studies of Human Pyridoxal 5′-Phosphate-Binding Protein (PLPBP) , 2019, ACS chemical biology.

[12]  Y. Sadzuka,et al.  In Vitro Anticancer Activities of B6 Vitamers: A Mini-review , 2019, AntiCancer Research.

[13]  P. Clayton,et al.  Disorders affecting vitamin B6 metabolism , 2019, Journal of inherited metabolic disease.

[14]  J. Jans,et al.  Discovery of pyridoxal reductase activity as part of human vitamin B6 metabolism. , 2019, Biochimica et biophysica acta. General subjects.

[15]  D. L. Graham,et al.  Human Serine Racemase: Key Residues/Active Site Motifs and Their Relation to Enzyme Function , 2019, Front. Mol. Biosci..

[16]  R. Pearson,et al.  Cystathionine β-Synthase in Physiology and Cancer , 2018, BioMed research international.

[17]  H. Blom,et al.  CBS mutations are good predictors for B6‐responsiveness: A study based on the analysis of 35 Brazilian Classical Homocystinuria patients , 2018, Molecular genetics & genomic medicine.

[18]  V. Rubio,et al.  Studies on cyanobacterial protein PipY shed light on structure, potential functions, and vitamin B6‐dependent epilepsy , 2017, FEBS letters.

[19]  B. Hartmann,et al.  Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation , 2017, Clinical genetics.

[20]  H. Per,et al.  Tyrosinemia type II: Novel mutations in TAT in a boy with unusual presentation , 2016, Pediatrics international : official journal of the Japan Pediatric Society.

[21]  Mostafa H. Ahmed,et al.  Inactive mutants of human pyridoxine 5′‐phosphate oxidase: a possible role for a noncatalytic pyridoxal 5′‐phosphate tight binding site , 2016, FEBS open bio.

[22]  Greg W. Clark,et al.  Panorama of ancient metazoan macromolecular complexes , 2015, Nature.

[23]  S. Vollset,et al.  Markers of vitamin B6 status and metabolism as predictors of incident cancer: The Hordaland Health Study , 2015, International journal of cancer.

[24]  S. Abdelhak,et al.  Novel and recurrent mutations in the TAT gene in Tunisian families affected with Richner-Hanhart syndrome. , 2013, Gene.

[25]  H. Hemmi,et al.  Conserved Pyridoxal Protein That Regulates Ile and Val Metabolism , 2013, Journal of bacteriology.

[26]  E. Barillot,et al.  Prognostic impact of vitamin B6 metabolism in lung cancer. , 2012, Cell reports.

[27]  Alessandro Paiardini,et al.  Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases , 2011, Proceedings of the National Academy of Sciences.

[28]  D. Higgins,et al.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.

[29]  D. Xie,et al.  Down‐regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma , 2010, Hepatology.

[30]  David R Westhead,et al.  The transcriptional regulation of protein complexes; a cross-species perspective. , 2009, Genomics.

[31]  Riccardo Percudani,et al.  The B6 database: a tool for the description and classification of vitamin B6-dependent enzymatic activities and of the corresponding protein families , 2009, BMC Bioinformatics.

[32]  E. Christensen,et al.  Identification of two new mutations in the TAT gene in a Danish family with tyrosinaemia type II , 2009, The British journal of dermatology.

[33]  D. Talwar,et al.  Relation between pyridoxal and pyridoxal phosphate concentrations in plasma, red cells, and white cells in patients with critical illness. , 2008, The American journal of clinical nutrition.

[34]  Martin C. Frith,et al.  Discovering Sequence Motifs with Arbitrary Insertions and Deletions , 2008, PLoS Comput. Biol..

[35]  B. Andresen,et al.  TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping , 2006, Journal of Inherited Metabolic Disease.

[36]  M. Nilges,et al.  Clinical and mutational investigations of tyrosinemia type II in Northern Tunisia: identification and structural characterization of two novel TAT mutations. , 2006, Molecular genetics and metabolism.

[37]  M. Martínez-Pardo,et al.  The p.T191M mutation of the CBS gene is highly prevalent among homocystinuric patients from Spain, Portugal and South America , 2006, Journal of Human Genetics.

[38]  Antje Gohla,et al.  Chronophin, a novel HAD-type serine protein phosphatase, regulates cofilin-dependent actin dynamics , 2005, Nature Cell Biology.

[39]  J. Bonham,et al.  The molecular basis of cystathionine ß‐synthase (CBS) deficiency in UK and US patients with homocystinuria , 2004, Human mutation.

[40]  Martin Vingron,et al.  IntAct: an open source molecular interaction database , 2004, Nucleic Acids Res..

[41]  Mengsu Yang,et al.  Interaction between pyridoxal kinase and pyridoxal-5-phosphate-dependent enzymes. , 2003, Journal of biochemistry.

[42]  G. Schneider,et al.  The manifold of vitamin B6 dependent enzymes. , 2000, Structure.

[43]  R. Coleman,et al.  Novel and recurrent tyrosine aminotransferase gene mutations in tyrosinemia typeII , 1998, Human Genetics.

[44]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[45]  N. Grishin,et al.  Modeling of the spatial structure of eukaryotic ornithine decarboxylases , 1995, Protein science : a publication of the Protein Society.

[46]  M. Di Rocco,et al.  Point mutations in the tyrosine aminotransferase gene in tyrosinemia type II. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[47]  F. Kwok,et al.  Interactions of pyridoxal kinase and aspartate aminotransferase emission anisotropy and compartmentation studies. , 1988, The Journal of biological chemistry.